论文部分内容阅读
为了进一步探讨米非司酮与PG05和PG口服药(简称米索)终止早孕的效果和副反应,我院于1993年3月至1994年7月对400例早孕妇女进行了不同配伍方案的药物抗早孕的观察。 1 对象和方法 1.1 用药对象选择:健康早孕妇女,停经49天以内,自愿要求药物终止妊娠,尿HCG阳性,无急慢性器质性病变,尤其是无心血管、血液及内分泌系统疾病,未使用宫内节育器。 1.2 药物方案及临床观察:第1组:米非司酮25mg,每日2次,早晚饭前后2小时空腹口服,服药
In order to further explore the mifepristone and PG05 and PG oral medication (referred to as misoprostol) termination of early pregnancy effect and side effects, our hospital from March 1993 to July 1994 on 400 cases of pregnant women with different compatibility programs of drugs Anti-pregnancy observation. 1 objects and methods 1.1 drug choice: healthy early pregnant women, menopause within 49 days, voluntary termination of pregnancy drug requirements, urine HCG positive, no acute and organic disease, especially without cardiovascular, blood and endocrine system diseases, unused Palace IUD. 1.2 drug programs and clinical observation: Group 1: mifepristone 25mg, 2 times a day, fasting 2 hours before and after fasting oral administration, medication